Rofo 2007; 179(12): 1236-1242
DOI: 10.1055/s-2007-963574
Übersicht

© Georg Thieme Verlag KG Stuttgart · New York

Fortschritte im Staging des Nierenzellkarzinoms mittels hochauflösender Bildgebung

Advances in the Staging of Renal Cell Carcinoma with High-Resolution ImagingP. Hallscheidt1 , G. Noeldge1 , S. Schawo1 , S. Bartling2 , G. Kauffmann1 , J. Pfitzenmaier3 , M. Palmowski1
  • 1Abt. Radiodiagnostik, Radiologische Klinik, Universität Heidelberg
  • 2Medizinische Physik, DKFZ Heidelberg
  • 3Urologische Klinik, Universität Heidelberg
Further Information

Publication History

eingereicht: 3.5.2007

angenommen: 26.8.2007

Publication Date:
14 November 2007 (online)

Zusammenfassung

Die modernen schnittbildgebenden Verfahren Computertomografie und MRT erlauben die zeitlich und räumlich hochaufgelöste Darstellung des gesamten Abdomens. Die therapeutischen Möglichkeiten des Nierenzellkarzinoms haben sich in den letzten Jahren deutlich erweitert. Neben der offenen und laparoskopischen Tumornephrektomie und der organerhaltenden Operation werden zunehmende lokale tumorablative Verfahren wie die Kryotherapie und die Radiofrequenzablation angewandt. Zeitgleich werden auch ausgedehnte Tumore mittels verbesserter anästhesiologischer Methoden und neuer operativer Verfahren einer kurativen Operation zugeführt. Die Anforderung an die präoperative Diagnostik geht entsprechend über die Frage des Tumornachweises und des Stagings hinaus. Tumorbedingte intrarenale Infiltrationen des Nierenbeckens oder großer hilusnaher Gefäße müssen bei der Planung einer organerhaltenden Operation ausgeschlossen werden. Bei ausgedehnten Tumoren mit Infiltration der Vena cava inferior muss die genaue craniale Ausdehnung des Tumorzapfens dargestellt werden. Der Radiologe sollte die Möglichkeiten und Grenzen der unterschiedlichen bildgebenden Methoden kennen und somit den Urologen bei der Planung des operativen Eingriffes unterstützen.

Abstract

Modern imaging modalities such as computed tomography (CT) and magnetic resonance imaging (MRI) allow high-resolution imaging of the abdomen. Modern scanners made high temporal as well as high spatial resolution available. Therapeutic approaches to the treatment of renal cell carcinoma have been improved over the recent years. Besides conventional and open laparoscopic tumor nephrectomy and nephron sparing, surgical approaches such as local tumor cryotherapy and radiofrequency ablation (RF) are ablative modalities and are used increasingly. Improved anesthesiological methods and new surgical approaches also allow curative treatment in extended tumors. Prerequisites for preoperative imaging modalities include visualization of the kidney tumor as well as its staging. Tumor-related infiltration of the renal pelvis or invasion of the perinephric fat and the renal hilus has to be excluded prior to nephron sparing surgery. In cases with extended tumors with infiltration of the inferior vena cava, it is necessary to visualize the exact extension of the tumor growth towards the right atrium in the vena cava. The radiologist should be informed about the diagnostic possibilities and limitations of the imaging modalities of CT and MRI in order to support the urologist in the planning and performance of surgical therapeutical approaches.

Literatur

  • 1 Simon G V. Chirurgie der Nieren. Stuttgart; Thieme 1871 und 1876
  • 2 Amercian Cancer Society .Cancer facts and Figures 2000. Atlanta, Ga; Amercian Cancer Society 2000
  • 3 Greene F, Page D, Morrow M. AJCC cancer staging manual. New York; Springer 2002 6th edition
  • 4 Ficarra V, Schips L, Guille F. et al . Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma.  Cancer. 2005;  104 968-974
  • 5 Salama M E, Guru K, Stricker H. et al . pT1 substaging in renal cell carcinoma: validation of the 2002 TNM staging modification of malignant renal epithelial tumors.  J Urol. 2005;  173 1492-1495
  • 6 Hafez K S, Fergany A F, Novick A C. Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging.  J Urol. 1999;  162 1930-1933
  • 7 Patard J J, Shvarts O, Lam J S. et al . Safety and efficacy of partial nephrectomy for all T 1 tumors based on an international multicenter experience.  J Urol. 2004;  171 2181-2185
  • 8 Zisman A, Pantuck A J, Chao D. et al . Reevaluation of the 1997 TNM classification for renal cell carcinoma: T 1 and T 2 cutoff point at 4.5 rather than 7 cm better correlates with clinical outcome.  J Urol. 2001;  166 54-58
  • 9 Elmore J M, Kadesky K T, Koeneman K S. et al . Reassessment of the 1997 TNM classification system for renal cell carcinoma.  Cancer. 2003;  98 2329-2334
  • 10 Bonsib S M. T2 clear cell renal cell carcinoma is a rare entity: a study of 120 clear cell renal cell carcinomas.  J Urol. 2005;  174 1199-1202
  • 11 Clayman R V, Kavoussi L R, Soper N J. et al . Laparoscopic nephrectomy.  N Engl J Med. 1991;  324 1370-1371
  • 12 Abbou C C, Cicco A, Gasman D. et al . Retroperitoneal laparoscopy versus open radical nephrectomy.  J Urol. 1999;  161 1776-1780
  • 13 Tacke J, Mahnken A H, Gunther R W. Perkutane Thermoablation von Nierentumoren.  Fortschr Röntgenstr. 2005;  177 1631-1640
  • 14 Schoepf U J, Bruening R D, Hong C. et al . Multislice helical CT of focal and diffuse lung disease: comprehensive diagnosis with reconstruction of contiguous and high-resolution CT sections from a single thin-collimation scan.  Am J Roentgenol. 2001;  177 179-184
  • 15 Hu H, He H D, Foley W D. et al . Four multidetector-row helical CT: image quality and volume coverage speed.  Radiology. 2000;  215 55-62
  • 16 Sheth S, Scatarige J C, Horton K M. et al . Current concepts in the diagnosis and management of renal cell carcinoma: role of multidetector CT and three-dimensional CT.  Radiographics. 2001;  21 237-254
  • 17 Catalano C, Fraioli F, Laghi A. et al . High-resolution multidetector CT in the preoperative evaluation of patients with renal cell carcinoma.  Am J Roentgenol. 2003;  180 1271-1277
  • 18 Gupta R, Grasruck M, Suess C. et al . Ultra-high resolution flat-panel volume CT: fundamental principles, design architecture, and system characterization.  Eur Radiol. 2006;  16 1191-1205
  • 19 Silverman S G, Lee B Y, Seltzer S E. et al . Small (<nor= 3 cm) renal masses: correlation of spiral CT features and pathologic findings.  Am J Roentgenol. 1994;  163 597-605
  • 20 Szolar D H, Kammerhuber F, Altziebler S. et al . Multiphasic helical CT of the kidney: increased conspicuity for detection and characterization of small (<3 cm) renal masses.  Radiology. 1997;  202 211-217
  • 21 Kopka L, Fischer U, Zoeller G. et al . Dual-phase helical CT of the kidney: value of the corticomedullary and nephrographic phase for evaluation of renal lesions and preoperative staging of renal cell carcinoma.  Am J Roentgenol. 1997;  169 1573-1578
  • 22 Yuh B I, Cohan R H. Different phases of renal enhancement: role in detecting and characterizing renal masses during helical CT.  Am J Roentgenol. 1999;  173 747-755
  • 23 Hallscheidt P, Pomer S, Roeren T. et al . Präoperatives Staging von Nierenzellkarzinomen mit Kavazapfen: welches diagnostische Verfahren? MRT oder CT - Prospektive histologisch kontrollierte Studie.  Urologe A. 2000;  39 36-40
  • 24 Kalinka A, Gerlach A, Arlart I P. et al . Charakterisierung und Staging von Nierentumoren: Bedeutung der MR-Diagnostik.  Fortschr Röntgenstr. 2006;  178 298-305
  • 25 Israel G M, Hindman N, Bosniak M. Evaluation of Cystic Renal Masses: Comparison of CT and MR Imaging by Using the Bosniak Classification System1.  Radiology. 2004;  231 365-371
  • 26 Hallscheidt P J, Fink C, Haferkamp A. et al . Preoperative staging of renal cell carcinoma with inferior vena cava thrombus using multidetector CT and MRI: prospective study with histopathological correlation.  J Comput Assist Tomogr. 2005;  29 64-68
  • 27 Schenk J P, Friebe B, Ley S. et al . Visualization of intrarenal vessels by 3.0-T MR angiography in comparison with digital subtraction angiography using renal specimens.  Pediatr Radiol. 2006;  36 1075-1081
  • 28 Roberts W W, Bhayani S B, Allaf M E. et al . Pathological stage does not alter the prognosis for renal lesions determined to be stage T 1 by computerized tomography.  J Urol. 2005;  173 713-715
  • 29 Siemer S, Lehmann J, Loch A. et al . Current TNM classification of renal cell carcinoma evaluated: revising stage T 3a.  J Urol. 2005;  173 33-37
  • 30 Kanofsky J A, Phillips C K, Stifelman M D. et al . Impact of discordant radiologic and pathologic tumor size on renal cancer staging.  Urology. 2006;  68 728-731
  • 31 Thompson R H, Leibovich B C, Cheville J c. et al . Is renal sinus fat invasion the same as perinephric fat invasion for pT3a renal cell carcinoma?.  J Urol. 2005;  174 1218-1221
  • 32 Han K R, Bui M H, Pantuck A J. et al . TNM T 3a renal cell carcinoma: adrenal gland involvement is not the same as renal fat invasion.  J Urol. 2003;  169 899-903
  • 33 Palapattu G S, Pantuck A J. Collecting system invasion in renal cell carcinoma impact on prognosis.  J Urol. 2003;  170 768-772
  • 34 Lam J S, Shvarts O, Leppert J T. et al . Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.  J Urol. 2005;  173 1853-1862
  • 35 Ljungberg B, Stenling R, Osterdahl B. Vein invasion in renal cell carcinoma.  J Urol. 1995;  154 1681-1684
  • 36 Moinzadeh A, Libertino J A. Prognostic significance of tumor thrombus level in patients with renal cell carcinoma and venous tumor thrombus extension. Is all T 3b the same?.  J Urol. 2004;  171 598-601
  • 37 Glazer A A, Novick A C. Long-term followup after surgical treatment for renal cell carcinoma extending into the right atrium.  J Urol. 1996;  155 448-450
  • 38 Zisman A, Wieder J A, Pantuck A. et al . Renal cell carcinoma with tumor thrombus extension: biology, role of nephrectomy and response to immunotherapy.  J Urol. 2003;  169 909-916
  • 39 Kim H L, Zisman A, Han K R. et al . Prognostic significance of venous thrombus in renal cell carcinoma. Are renal vein and inferior vena cava involvement different?.  J Urol. 2004;  171 588-591
  • 40 Blute M L, Leibovich B C, Lohse C M. et al . The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus.  BJU Int. 2004;  94 33-41
  • 41 Hallscheidt P, Besharati S, Noeldge G. et al . Präoperative und palliative Embolisation des Nierenzellkarzinoms: Nachsorge von 49 Patienten.  Fortschr Röntgenstr. 2006;  178 391-399
  • 42 Hallscheidt P, Wagener N, Gholipour F. et al . Multislice computed tomography in planning nephron-sparing surgery in a prospective study with 76 patients: comparison of radiological and histopathological findings in the infiltration of renal structures.  J Comput Assist Tomogr. 2006;  30 869-874
  • 43 Kramer U, Nael K, Laub G. et al . High-resolution magnetic resonance angiography of the renal arteries using parallel imaging acquisition techniques at 3.0 T: initial experience.  Invest Radiol. 2006;  41 125-132
  • 44 Johnson C D, Dunnick N R, Cohan R H. et al . Renal adenocarcinoma: CT staging of 100 tumors.  AJR Am J Roentgenol. 1987;  148 59-63
  • 45 Gill I S, McClennan B L, Kerbl K. et al . Adrenal involvement from renal cell carcinoma: predictive value of computerized tomography.  J Urol. 1994;  152 1082-1085
  • 46 Canfield S E, Kamat A M, Sanchez-Ortiz R F. et al . Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1 - 2 M0): the impact of aggressive surgical resection on patient outcome.  J Urol. 2006;  175 864-869

Prof. Dr. Peter Hallscheidt

Radiologisches Institut, Uniklinik Heidelberg

Im Neuenheimer Feld 110

69120 Heidelberg

Phone: ++ 49/62 21/56 64 10

Fax: ++ 49/62 21/56 57 30

Email: hallscheidt@yahoo.de

    >